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Genomic imprinting occurs where only one allele of a gene is 
expressed depending on its parental origin. The imprinted Igf2 
gene (Insulin-like growth factor 2) is encoding a growth factor, 
which play an important role in embryonic development and 
formation of the placenta. The regulation and expression of Igf2 
is carried out by different promoters. Promoter expression is 
extremely complex in wild-type mice during development and is 
altered in several mutant mice bearing deletions at the Igf2/H19 
locus. In this work, we analyzed the Igf2 RNA expression of the 
placenta-specific P0 promoter in placental tissue (embryonic day 
17) of both wild-type and mutant mice. For all the other 
promoters, we used RNA extracted from liver tissues (postnatal 
day 7.5). All these RNAs were reverse transcribed to cDNA 
before quantifying expression levels of the promoters by 
quantitative PCR (qPCR).Our results show that transcriptions 
of Igf2 P2 and P3 promoters are the highest in all mice 
analyzed, except in ΔU2/Dom mutant mice where P0 and P1 
promoters were highly expressed, while they display low 
expression in all the other mice strains analyzed. Furthermore, 
all promoters were stably expressed at high levels in wild-type 
and ΔU2/Dom mutation, but at a low level in Δ3/Dom 	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Introduction 
 
A typical human cell expresses only about 20% of the total number genes at a 
determined time, from all of them, only 1.5% are coding for proteins [2]. Gene 
expression refers to the processes that translates the genetic information of the 
genes to mRNAs and proteins. The expression of each gene is controlled and 
tightly regulated by various mechanisms within the cell. The main elements 
controlling the expression process are gene promoters. A promoter is a region of 
DNA that initiates transcription of a particular gene. Promoters are located 
around transcription start sites (TSS) of genes, on the same strand and upstream 
on the coding DNA sequence. Promoters can be about 100 -1000 base-pair long 
[17]. A gene can be controlled by one or several promoters. Researches on the 
mechanism of expression and regulation of gene expression in eukaryotes, and 
more particularly in mice, are particularly complex, especially for imprinting 
genes [3, 7]. The expression of the Insulin-Like Growth Factor 2 (Igf2) gene is 
quite complex because it is carried out by several promoters and only on the 
paternally inherited allele. The expression level of the different promoters is 
completely different depending on the tissue and the mouse strain [4, 5, 19]. In 
mammals, embryonic growth and development are controlled by a number of 
genes, among them is Igf2. This imprinted gene is located on the chromosome 
11p15 in humans and the chromosome 7 in mice. It is paternally expressed both 
in humans and in mice. The regulation of Igf2 gene expression is extremely 
complex. The abnormal expression, loss imprinting or hypermethylation of this 
gene lead to the Beckwith-Wiedemann syndrome, the Silver-Russell syndrome or 
Wilms’ tumors in children. In the adult, it is also involved in some pathways 
leading to cancers [1, 14, 20]. When the Igf2 gene was inactivated in mouse 
embryos, the weight of the offspring was 40% lower than the normal offspring 
issued from the same litter [6, 15]. Knockout of the endodermic specific enhancers, 
located at the Igf2/H19 locus, results is fetuses lacking Igf2 expression in the 
endoderm [9, 18]. Many subsequent studies have confirmed that Igf2 gene plays 
an important and direct role in the proliferation, differentiation and 
differentiation of cells in mammals [6]. There are 4 promoters that are driving Igf2 
expression levels, among them P1-P3 are transcribed in all tissues, while P0 is 
expressed specifically in the placenta [4, 11, 12]. There are some significant 
differences in the size of the resulting transcripts [10, 13]. Furthermore, this gene 
also plays an important role in the development and differentiation of the 
placenta. In the Igf2 knockout mice, the size of the placenta was reduced, 
resulting in body weight at birth that is only 60% compared to wild mice wild [6, 
8]. However, the tissue-specific expression level of the different promoters in wild 
and mutant mice has not yet been much explored. 
 
 
Materials and Methods 
 
Generation of mouse crosses 
 
Mus musculus mice was fed at the Institute of Molecular Genetics of 
Montpellier (France). Several crosses were generated. In the SD7/Dom and 
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Dom/SD7 crosses, the paternal chromosomes are either wild type or issued from 
the Mus spretus strain (SD7). The H19Δ3 mutant strain were provided by Luisa 
Dandolo’s laboratory (INSERM Paris, France) [15]. Δ3/Dom is a cross where the 
maternal allele of the H19 gene is removed. H19 is an imprinted gene, repressed 
on the paternal allele and located in the same locus as Igf2. It is encoding a non-
coding RNA that participates in the Igf2 gene regulation (Figure 1). U2/Dom is a 
mutant mouse cross that removes the U2 exon on the maternal Igf2 allele. 
 
 
 
 
Figure 1. Genomic map of mutant mouse Δ3/Dom and ΔU2/Dom 
 
Primers are used in the experiments are shown in table 1. 
 
Table 1. Primer sequences 
Amplicon names Forward primer sequence Reverse primer sequence 
P0 mRNA 5'-ATTGACCCAGCCAGCGGATC-3' 5'-CTGTACTCTAGTCGCTTCGTAG-3' 
P1 5'-CTCGTCACTTCTCCTACGGTG-3' 5'-CCCAGTCGTTTTCCTGGACAC-3' 
P2 5'-GTTCTGTCCCGTCGCACATT-3' 5'-GGTATGCAAACCGAACAGCG-3' 
P3 5'-CTGGACATTAGCTTCTCCTG-3' 5'-CTGAAGTTGGGTAAGGAGGC-3' 
Igf2 total* 5'-CATCGTCCCCTGATCGTGTTAC-3' 5'-GGAACTGTCCCTGCTCAAGA-3' 
5’Race 5'-CGACTGGAGCACGAGGACACTGA-3'  
GeneRacer RNA oligo 5’CGACUGGAGCACGAGGACACUGACAUGGACUGAAGGAGUAGAAA3’ 
*this amplification allows quantification of Igf2 mRNAs issued from all known promoters. 
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DNA extraction  
 
Tissue are homogeneized at room temperature in 2ml of buffer. 40 μl 
proteinase (20 μg /ml) dissolved in  pK 2X buffer are then added. After 4 hours 
of incubation at 50°C, the reaction is extracted with 4 ml of phenol/chloroform 
(1:1) and centrifugated for 30 minutes at 20°C at 6000 rpm. The supernatant is 
precipitated with 8 ml of EtOH and 300 μl of NaCl 5M at -20°C for 12 hours or 
overnight. The reaction is centrifugated to collect the RNA pellet that is washed 
with 500 μl 70% EtOH. The DNA is then dried at room temperature. 
 
 
Extraction of total RNA  
 
Total RNA extraction is similar to DNA with few differences: after adding the 
PK, we performed a Dnase I treatment to remove DNA. During extraction (by 
acidic phenol), centrifugation is carried out at low temperature (4°C). After the 
total RNA was obtained, total RNA extraction through the column containing 
oligo dT to separate the mRNA from the mixture. The mRNA is then recovered 
by elution. 
 
 
Preparation of cDNA  
 
To 2 μg of DNase treated RNA, add 1 μl of random primer or specific primer 
and 10 μl of sterile H2O. Incubate at 70°C for 10 minutes and then place in the 
ice for 5 minutes. Add 4 μl of buffer 5X (FS), 2 μl of DTT 0.1 M, 1 μl of dNTP 
2.5 mM, 0.7 μl of reverse transcriptase. Stabilize the mixture for about 10 
minutes at room temperature and incubate at 42°C for 1 hour. The cDNA is 
purified by glass balls and washing solution. Dilute cDNA 10 times for 
quantitative PCR or storage at -20°C. 
 
 
Quantitative PCR 
 
In this work, the Gapdh reference gene is used to calculate the relative 
quantities of mRNAs of the target gene (Igf2) expressed in the samples. The 
reaction mixture consists of 1 μl of cDNA (5 ng/μl), 1 μl of qPCR mix 
(containing dNTP, MgCl2, qPCR 10X buffer), 0.5 μl of each primers (10 μM 
stocks) and 7 μl of sterilized water. The positions of the primers used in the 
experiments are shown in figure 2 (black arrowheads). PCR program: 95°C, 2 
minutes and then 41 cycles (95°C/5 s; 52°C/15 s; 72°C/30 s). 
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Figure 2. Map showing Igf2 promoters and the positions of the primers used in the experiments. The “Igf2 total” 
amplicon was designed to target exon 6 which is common to all known Igf2 mRNAs (issued from all promoters). 
 
 
The 5’RACE method 
 
This method is used to screen new putative promoters. To 2μg of DNase 
treated ARN, add 1 μl of Buffer CIP (Calf Instestine Alakine Phosphatase) 10 X, 
1μl of RNAseOut (40U/μl), 1μl of CIP (10U/1μl) and 5μl of DEPC. Incubate at 
50°C for 1 hour, then add 90 μl of DEPC and 100 μl phenol:chloroform. Vortex 
strongly during 30 seconds. Centrifuge at 16000rpm for 5 minutes at room 
temperature. Collect the supernatant and add 2 μl of glycogen (10mg/ml), 10 μl 
of 3M sodium acetate (pH 5.2) and mix well. Add 220 μl of 95% ethanol, vortex, 
put on ice for about 10 minutes. Centrifuge at 4°C for 20 minutes (16000rpm), 
wash the pellet with 500 μl of 70% ethanol. Centrifuge, dry and add 7 μl of 
DEPC. Add 1 μl of TAP  (Tobacco Acid Pyrophosphate) buffer 10X, 1 μl of 
RNaseOut (40U/μl), 1 μl of TAP (0.5 U/μl) (total volume is 10 μl). Gently shake 
and incubate at 37°C for 1 hour. Then centrifuge to precipitate the RNA and 
dissolve in 7 μl of DEPC. Next, add this reaction into a tube containing the 0.25 
μg of GeneRacer RNA Oligo, incubating at 65°C for 5 minutes, cool the tube in 
ice for 2 minutes and add 1 μl of 10X ligase buffer, 1 μl of ATP (10 mM), 1 μl of 
RnaseOut (40 U/μl), 1 μl of T4 RNA ligase(5 U/μl). Incubate at 37°C for 1 hour 
and then centrifuge to collect RNA and add 10 μl of DEPC water. Store this 
reaction at -20°C. 
 
 
Results  
 
Amplification sizes of Igf2 transcripts 
 
Total DNA and RNA was extracted from 7.5 day-old mouse livers according 
to the method described above. DNA was tested on agarose gel (Figure 3A). The 
image of DNA shows that the total DNA was not broken and relatively clean, 
and thus of good quality. The RNA was tested on agarose gel (Figure 3B) before 
quantification by spectrophotometer at 260 nm. The concentration were 
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determined to be 25 μg/ml. This concentration was sufficient to carry out qPCR 
quantifications. 
 
 
  
Figure 3. Image of total DNA (A) RNA (B) extracted from in wild mouse liver (d.7.5). The size of the amplicons 
obtained from the different Igf2 specific promoters were check in an agarose gel (C). M (100bp marker). 
 
 
The Igf2 gene is located on mouse chromosome 7 and on human 
chromosome 11. In the mouse, this gene has a complex structure 
with 8 exons (U1, U2, 1,2,3,4,5,6) and four promoters (P0, P1, P2, 
P3). The size of the Igf2 mRNAs varies according to the length of 
each promoters. There are 3 exons (exons 4, 5, 6) are common to all 
transcripts and exon 4 contains the start codon. 
Using cDNA from the Dom/SD7 cross (wild mouse) and 
promoter-specific primers, we quantify Igf2 gene expression from 
each promoters. The sizes of the resulting amplicons were as 
expected from the reference sequence of the mouse genome (P0: 120 
bp, P1: 98 bp, P2: 135 bp, Igf2total: 201 bp, P3: 132 bp) (Figure 
3C). It means that these primers are specifically designed for 
promoters and cDNA. These primers continue to be used to 
quantify the expression levels of different promoters in different 
mice. 
 
 
Identification of a new placental transcript  
 
Using the 5'RACE technique, we have identified a new Igf2 
transcript in the mouse placenta. The transcription start site of this 
novel transcript is located within the U2 exon of the Igf2 gene. The 
new exon is 136 nucleotides in size and is named PU2 (Figure 4). 
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Figure 4. PU2 transcript position is depicted relative to the other Igf2 promoters (A). The sequence of the new PU2 
promoter is shown (B, C). 
 
 
Expression levels of specific Igf2 promoters 
 
RNA from placental tissue (e17) was extracted from wild-type and mutant 
mouse strains and used for quantifications of the P0 promoter [16], while RNA 
from 7.5 days-old mouse livers was used to quantify all other Igf2 promoters. The 
level of expression of each promoters was compared to the expression level of the 
total Igf2 mRNA (100%). The highest expression levels were observed for the P3 
promoter (80%), to P2 (35%), followed by P1 (20%) and the lowest is P0 (7%) 
(Figure 5). 
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Figure 5. Levels of promoter expression (P0, P1, P2, P3), in wild mice in correlation with total Igf2 expression 
 
Igf2 is a maternally imprinted gene, therefore its expressed arises only from 
alleles derived from the paternal chromosome. Thus, the elimination of the U2 
exon on the maternal alleles in the ΔU2/Dom cross has virtually no effect on the 
expression level of this gene. 
 
 
Figure 6. Levels of promoter expression (P0, P1, P2, P3) in wild mouse and mutant mouse cloning (using the Gapdh 
reference gene). 
 
In contrast, in the two wild-type crosses (SD7/Dom and Dom/SD7), P0 and 
P1 exhibited stable but low levels (less than 50%) (Figure 6). We can see that 
the all promoters exhibited stable expression in the two wild-type crosses, but the 
expression decreased sharply when the H19Δ3 mutation occurred on the 
maternal allele (Δ3/Dom cross). 
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Discussion  
 
Studies of RNA expression levels are often using the Northern-blot method. 
Northern-blots are usefull to study the size of full lenght mRNA molecules, but 
they often provide little knowledge on the identity of the mRNA variants that 
are vizualised. That is why, in this work, we prefered to use RT-qPCR and 
5’RACE methods.  
Our work shows that, when studying the expression of a mRNA, it is not only 
required to study different tissues at different developmental stages, but it is also 
necessary to check the expression levels throughout the entire mRNA molecule. 
This is particularly true for the Igf2 mRNAs for which the expression levels were 
here investigated at only four different promoters and two tissues (liver and 
placenta). Indeed, the Igf2 gene can be divided into three main areas that provide 
different mRNA molecules displaying different expression levels. The first area is 
encompassing the region of the promoters, the second area is containing the 
common exons (4,5,6) and the third area is the 3' region that contains the polyA 
tail signal (Figure 6). 
 
 
Figure 6. Main areas for study of Igf2 RNA expression 
 
 
Wolfgang et al. (2011), among promoters of Igf2 in humans, P3 and P4 
(equivalent to P2 and P3 in mice) contributed significantly to the total number 
of copies of Igf2, meaning that they were most strongly expressed in correlates 
with other promoters. Explaining this phenomenon, he said that, as the enhancer 
activated the differential methylated DMR2 region, it was itself considered to be 
a activative factor for two adjacent promoters [21]. 
When quantifying the expression levels of promoters in different mice, the 
results showed that all promoters exhibited low levels in the Δ3/Dom mutation, 
because of deletion of the H19 gene. This gene regulated the expression of Igf2 
via a methylation-sensitive mechanism that is no longer active in the Δ3/Dom 
mutant, thus reducing the level of transcription of Igf2. In other mutants 
(ΔU2/Dom) as well as wild type, the expression levels of the promoters were 
quite high compared to the Δ3/Dom, especially P2 and P3, and were quite 
stable. About P0 and P1 promoters, only high expression in mutant ΔU2/Dom. 
 
 
 
 
Open  Science  Journal  
Research Article 
Open  Science  Journal–November  2017      10  
Conclusion 
    
Specific primers for each promoter are designed and amplified precisely the 
size of each promoter from the cDNA (P0: 120 bp, P1: 98 bp, P2: 135 bp, P3: 132 
bp, total Igf2: 201 bp). We have identified a new transcript in the mouse 
placenta, located on the U2 exon of the Igf2 gene. This new transcript is 136 
nucleotides and is named PU2. In wild type mouse, the P3 promoter exhibited 
the highest (80%), followed by P2 (35%), and the remaining 2 promoters were 
lower than the total Igf2, P1 and P0 (less than 20%). There are different 
expressions of promoters in mutant and wild type mouse. The promoters 
exhibited low levels in the mutant Δ3/Dom. P2 and P3 are highly expressed and 
stable in both wild and mutant ΔU2/Dom. P0 and P1 are highly expressed only 
in the mutation ΔU2/Dom.  
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